SoLAT (Sorafenib Lenvatinib alternating treatment): A new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer

Soo Young Kim, Seok Mo Kim, Ho Jin Chang, Bup Woo Kim, Yong Sang Lee, Cheong Soo Park, Ki Cheong Park, Hang Seok Chang

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'SoLAT (Sorafenib Lenvatinib alternating treatment): A new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences